Labcorp (LH)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$283.76-0.22%
Close 2026-07-07 · 1-day change
Reading LH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LH free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading LH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LH free→QuarterlyIQ Insights · LH
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(2.4) + peer(0.2*3.9) + term(2.0) → 3.6% (capped ±15.0)
in 22 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition On July 28, 2022, Laboratory Corporation of America Holdings (Labcorp) issued a press release reporting financial results for the three months ended June 30, 2022. A copy of Labcorp’s press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.